Killing the Golden Goose of U.S. Drug Innovation: Follow the Money (Part I)
NEWS, PRESS -In the first of a two-part series, Banner Witcoff’s Mercedes Meyer and Brandon Phemester of Novavox explore how legislative, judicial, and executive policies have dramatically altered the risks for drug